Neuropace Inc (NPCE)

Healthcare Healthcare Services Healthcare Equipment & Supplies

Verfolgen Share on 𝕏

Aktien-Chart
Tickersymbol: NPCE Börsenplatz: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Kauf • Verkauf • Geplanter Kauf • Geplanter Verkauf Netto-Kauf Netto-Verkauf
Letzte 90 Tage
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
Datum der Benachrichtigung Datum der Transaktion K/V Art der Transaktion Insider und/oder position Anz. der Aktien
Kurs
Wert 		Anzahl der Aktien Kurs Gesamtwert Details
2024-05-03 2024-05-03 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
4.674 -0.1%
14,03
65.576 USD 		4.674 -0.1% 14,03 65.576 USD
2024-05-03 2024-05-02 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
8.842 -0.3%
14,01
123.876 USD 		8.842 -0.3% 14,01 123.876 USD
2024-05-03 2024-05-01 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
15.690 -0.5%
14,02
219.974 USD 		15.690 -0.5% 14,02 219.974 USD
2024-04-26 2024-04-24 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
1.781 -0.1%
14,06
25.041 USD 		1.781 -0.1% 14,06 25.041 USD
2024-04-23 2024-04-23 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
21.791 -0.6%
14,29
311.393 USD 		21.791 -0.6% 14,29 311.393 USD
2024-04-23 2024-04-22 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
24.609 -0.7%
14,05
345.756 USD 		24.609 -0.7% 14,05 345.756 USD
2024-04-23 2024-04-19 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
18.253 -0.5%
14,02
255.907 USD 		18.253 -0.5% 14,02 255.907 USD
2024-04-18 2024-04-18 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
2.623 -0.1%
14,06
36.879 USD 		2.623 -0.1% 14,06 36.879 USD
2024-04-18 2024-04-17 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
300 -0.0%
14,15
4.245 USD 		300 -0.0% 14,15 4.245 USD
2024-04-18 2024-04-16 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
14.069 -0.4%
14,01
197.107 USD 		14.069 -0.4% 14,01 197.107 USD
2024-04-15 2024-04-12 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
23.101 -0.7%
14,42
333.116 USD 		23.101 -0.7% 14,42 333.116 USD
2024-04-15 2024-04-11 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
461.899 -11.5%
14,49
6.692.917 USD 		461.899 -11.5% 14,49 6.692.917 USD
2024-02-06 2024-02-05 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
3.446 -4.2%
15,17
52.278 USD 		3.446 -4.2% 15,17 52.278 USD
2024-02-06 2024-02-02 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
14.143 -14.8%
15,07
213.122 USD 		14.143 -14.8% 15,07 213.122 USD
2024-02-01 2024-02-01 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
663 -0.7%
15,04
9.971 USD 		663 -0.7% 15,04 9.971 USD
2024-02-01 2024-01-31 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
1.923 -2.0%
15,08
28.990 USD 		1.923 -2.0% 15,08 28.990 USD
2024-02-01 2024-01-30 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
11.262 -10.3%
15,10
170.004 USD 		11.262 -10.3% 15,10 170.004 USD
2024-01-26 2024-01-25 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
1 -0.0%
15,00
15 USD 		1 -0.0% 15,00 15 USD
2024-01-26 2024-01-24 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
827 -0.8%
15,03
12.426 USD 		827 -0.8% 15,03 12.426 USD
2023-12-28 2023-12-27 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
13.300 -10.8%
10,12
134.648 USD 		13.300 -10.8% 10,12 134.648 USD
2023-12-28 2023-12-26 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
102 -0.1%
10,00
1.020 USD 		102 -0.1% 10,00 1.020 USD
2023-12-22 2023-12-20 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
2.730 -2.2%
10,14
27.695 USD 		2.730 -2.2% 10,14 27.695 USD
2023-12-07 2023-12-06 GV Geplanter Verkauf

Morrell Martha

Chief Medical Officer

Führungsperson
11.005 -8.0%
8,16
89.773 USD 		11.005 -8.0% 8,16 89.773 USD
2023-12-01 2023-12-01 V Verkauf

KCK LTD.

Large shareholder
3.241 -0.1%
8,73
28.294 USD 		3.241 -0.1% 8,73 28.294 USD
2023-12-01 2023-11-30 V Verkauf

KCK LTD.

Large shareholder
7.282 -0.1%
8,84
64.373 USD 		7.282 -0.1% 8,84 64.373 USD
2023-12-01 2023-11-29 V Verkauf

KCK LTD.

Large shareholder
5.644 -0.1%
8,72
49.216 USD 		5.644 -0.1% 8,72 49.216 USD
2023-11-29 2023-11-28 V Verkauf

KCK LTD.

Large shareholder
4.681 -0.1%
8,75
40.959 USD 		4.681 -0.1% 8,75 40.959 USD
2023-11-29 2023-11-27 V Verkauf

KCK LTD.

Large shareholder
6.490 -0.1%
8,96
58.150 USD 		6.490 -0.1% 8,96 58.150 USD
2023-10-04 2023-10-03 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
700 -0.0%
9,02
6.314 USD 		700 -0.0% 9,02 6.314 USD
2023-10-04 2023-10-02 V Verkauf

ORBIMED ADVISORS LLC

Large shareholder
7.614 -0.2%
9,08
69.135 USD 		7.614 -0.2% 9,08 69.135 USD
2022-11-23 2022-11-22 K Kauf

Accelmed Partners II L.P.

Large shareholder
62.398 +1.4%
1,50
93.535 USD 		62.398 +1.4% 1,50 93.535 USD
2022-11-23 2022-11-21 K Kauf

Accelmed Partners II L.P.

Large shareholder
327.893 +8.1%
1,50
491.512 USD 		327.893 +8.1% 1,50 491.512 USD
2022-06-09 2022-06-08 GV Geplanter Verkauf

Ridley Irina

General Counsel and Secretary

Führungsperson
2.500 -3.9%
5,78
14.445 USD 		2.500 -3.9% 5,78 14.445 USD
2022-03-01 2022-02-28 GV Geplanter Verkauf

Ridley Irina

General Counsel and Secretary

Führungsperson
1.470 -18.1%
7,54
11.082 USD 		1.470 -18.1% 7,54 11.082 USD
2021-04-23 2021-04-21 K Kauf

Norton Evan

Nicht geschäftsführender Verwaltungsratsmitglied
588.235 +inf%
17,00
9.999.995 USD 		588.235 +inf% 17,00 9.999.995 USD
2021-04-23 2021-04-21 K Kauf

ORBIMED ADVISORS LLC

Large shareholder
235.000 +inf%
17,00
3.995.000 USD 		235.000 +inf% 17,00 3.995.000 USD
2021-04-23 2021-04-21 K Kauf

Accelmed Partners II L.P.

Large shareholder
588.235 +inf%
17,00
9.999.995 USD 		588.235 +inf% 17,00 9.999.995 USD
2021-04-23 2021-04-21 K Kauf

Fischer Frank M

Nicht geschäftsführender Verwaltungsratsmitglied
50.000 +115.5%
17,00
850.000 USD 		50.000 +115.5% 17,00 850.000 USD
2021-04-23 2021-04-21 K Kauf

Garfield Greg Shaw

Nicht geschäftsführender Verwaltungsratsmitglied
13.235 +51.7%
17,00
224.995 USD 		13.235 +51.7% 17,00 224.995 USD
2021-04-23 2021-04-21 K Kauf

Ridley Irina

General Counsel and Secretary

Führungsperson
2.352 +inf%
17,00
39.984 USD 		2.352 +inf% 17,00 39.984 USD